BURLINGTON, N.C., April 29, 2024 /PRNewswire/ -- Labcorp (LH) (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the U.S. Food and Drug Administration ...

Labcorp’s (NYSE:LH) assay has been cleared by the U.S. drug regulator for use with Pfizer's (NYSE:PFE) newly approved gene therapy to treat patients with hemophilia B. The U.S. Food and Drug ...

If a patient tests positive for antibodies to AAVRh74var, Beqvez should not be administered. Beqvez is indicated for the treatment of adults with moderate to severe hemophilia B who currently use ...

The FDA has bestowed a green light to a companion diagnostic for Pfizer’s recently approved hemophilia B gene therapy—because, at a cost of $3.5 million per dose, you want to make sure it will work.

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Developing robust, reproducible antibody pair-based immunoassays is critical for guiding drug ...

Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

When we hear that a person has quirks, we expect to be charmed. But when we hear that a cell-based assay has quirks, we expect to be frustrated. Quirks in cell-based assays tend to complicate drug ...